好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Novel FLAMES Presentation in Anti-MOG Encephalitis with FLAIR-Hyperintense Lesions
Autoimmune Neurology
P11 - Poster Session 11 (8:00 AM-9:00 AM)
8-002
NA
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is an inflammatory condition of the central nervous system, characterized by episodes of immune-mediated demyelination that commonly affect the optic nerves, brain, and spinal cord. While this disease predominantly affects children, it can present in adults with distinct clinical and radiographic features. FLAIR-hyperintense lesions in anti-MOG associated encephalitis with seizures (FLAMES) represent a clinicoradiographic sub-entity of MOGAD, distinguished by specific imaging findings and seizure activity.

A previously healthy 32-year-old male presented to the emergency room after experiencing bilateral tonic-clonic seizures with tongue biting and loss of consciousness. This was followed by a 40-minute period of postictal confusion and non-fluent aphasia.

Four days prior to this, the patient had exhibited brief hyperkinetic dystonic movements in the right cervical and facial region. Family members also reported notable behavioral changes, including irrelevant responses during conversations, prolonged latency in answering questions, and transient difficulty in communication. These behavioral symptoms lasted for approximately two weeks and then resolved spontaneously.

Neurological examination demonstrated non-fluent aphasia and motor deficits. MRI findings revealed precentral and postcentral leptomeningeal enhancement, along with FLAIR-hyperintense lesions, in line with a diagnosis of FLAMES. Cerebrospinal fluid analysis showed pleocytosis at 41 leukocytes/µL (reference rage <5/µ). The patient was treated with high-dose corticosteroids and remained seizure-free at the 6-month follow-up. Subsequent testing for anti-MOG antibodies returned positive, confirming the diagnosis of MOGAD, with FLAMES as the primary clinical and radiological presentation.



NA
This case highlights FLAMES as a rare but significant manifestation of MOGAD in adults. The combination of seizure activity, subtle behavioral changes, and FLAIR-hyperintense lesions underscores the importance of early recognition of this condition. Positive anti-MOG antibodies confirmed the diagnosis of MOGAD. Early intervention with high-dose corticosteroids resulted in a favorable outcome, reinforcing the need for prompt diagnosis and treatment to prevent long-term neurological complications.
Authors/Disclosures
Jairo A. Gaitan Alfonso, MD (Fundación Santa Fe de Bogotá)
PRESENTER
Dr. Gaitan Alfonso has nothing to disclose.
Juan P. Rodriguez noriega, MD Dr. Rodriguez noriega has nothing to disclose.
Jaime Toro, MD, FAAN (Universidad El Bosque) Dr. Toro has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Watch Neurology .
Maria Zafra-Sierra, MD (Fundación Santa Fe de Bogota) Dr. Zafra-Sierra has nothing to disclose.
Estefania Rojo-Bustamante, MD, PhD Dr. Rojo-Bustamante has nothing to disclose.
Saul Reyes, MD (The Royal London Hospital) Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BIIB. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen.